Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 19, 2014
Pharmacy Choice - Pharmacy News - December 19, 2014

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
12/19/14 - FDA Approves Bovie Ultimate Generator [Health & Beauty Close - Up]
Bovie Medical has received FDA 510 approval for the Bovie Ultimate generator. According to a release from Bovie Medical, the Bovie Ultimate is a high frequency electrosurgical generator that can be used for delivery of RF energy and/or helium gas plasma to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.
12/19/14 - FDA Approves Somatuline Depot (lanreotide) Injection [Health & Beauty Close - Up]
Ipsen Biopharmaceuticals reported that Somatuline Depot Injection 120 mg was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival.
12/19/14 - FDA Grants Approval to Cerus to Intercept Blood System for Plasma [Health & Beauty Close - Up]
Cerus said that the U.S. Food and Drug Administration has approved the Intercept Blood System for plasma. In a release, Cerus reported that the Intercept plasma system is approved for ex vivo preparation of plasma in order to reduce the risk of transfusion-transmitted infection when treating patients requiring therapeutic plasma transfusion.
12/19/14 - iGrow hair growth helmet from Boca cleared for women [Sun Sentinel]
Dec. 19-- Apira Science, which makes a laser helmet system to grow hair, has received FDA marketing clearance for sales to women. Apira, based in Boca Raton, received FDA clearance for sales to men in 2012. Clearance by the FDA doesn't mean a product works, only that it's not harmful. The iGrow system, which retails for $695, is sold online at igro
12/18/14 - Elekta Flexitron brachytherapy treatment delivery available in China
--Elekta announces that the China Food and Drug Administration has approved Elekta's Flexitron ® brachytherapy afterloading platform for sale and marketing in China. In China there is a high prevalence of gynecologic cancers, as well lung, breast, colorectum and esophagus cancers. Anming Gong, Elekta's Managing Director for China, says: " Elekta i
12/18/14 - EOS imaging Receives FDA Approval for hipEOS [Health & Beauty Close - Up]
EOS imaging reported that the U.S. Food and Drug Administration has approved hipEOS, a 3 D hip arthroplasty planning software based on EOS stereo-radiographic 2 D/3D imaging. Developed by OneFit medical, an EOS imaging group company, the software enables surgeons to perform, using EOS unique stereo- radiographic 2 D/3D low dose images, pre-surgical

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Newest and Most Current Medications in the Treatment of Diabetes
This lesson is supported by:
RxSchool
Medication Errors: A Patient Safety and Quality Improvement Program
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415